Deciphering the molecular genetic basis of NPC through functional approaches

Seminars in Cancer Biology

Volumn 22, Issue 2, 2012, Pages 87-95

  Lung, Hong Lok ^a   Cheung, Arthur Kwok Leung ^a   Ko, Josephine Mun Yee ^a   Cheng, Yue ^a   Stanbridge, Eric J ^b   Lung, Maria Li ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Microcell hybrid; Microcell mediated chromosome transfer; Nasopharyngeal carcinoma; Tumor segregant; Tumor suppressor gene

Indexed keywords

ONCOPROTEIN; THROMBOSPONDIN;

ADAMTS9 GENE; BLU GENE; CADM1 GENE; CARCINOGENESIS; CDKN2A GENE; CELL ADHESION; CELL CYCLE ARREST; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; CRIP2 GENE; CRYAB GENE; DUSP6 GENE; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FBLN2 GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE MAPPING; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; LTBP2 GENE; MIPOL1 GENE; MMP19 GENE; MOLECULAR GENETICS; NASOPHARYNX CARCINOMA; PLASMID; PROMOTER REGION; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PTPRG GENE; RASSF1A GENE; REVIEW; SIGNAL TRANSDUCTION; THY1 GENE; TUMOR SUPPRESSOR GENE;

EID: 84857786329     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2011.11.002     Document Type: Review

References (90)

1. Harris H., Miller O.J., Klein G., Worst P., Tachibana T. Suppression of malignancy by cell fusion. Nature 1969, 223:363-368.
2. Jonasson J., Povey S., Harris H. The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci 1977, 24:217-254.
3. Stanbridge E.J. Suppression of malignancy in human cells. Nature 1976, 260:17-20.
4. Stanbridge E.J., Der C.J., Doersen C.J., Nishimi R.Y., Peehl D.M., Weissman B.E., et al. Human cell hybrids: analysis of transformation and tumorigenicity. Science 1982, 215:252-259.
5. Cheng Y., Poulos N.E., Lung M.L., Hampton G., Ou B., Lerman M.I., et al. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 1998, 95:3042-3047.
6. Dafou D., Ramus S.J., Choi K., Grun B., Trott D.A., Newbold R.F., et al. Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells. Int J Cancer 2009, 124:1037-1044.
7. Fukuhara H., Maruyama T., Nomura S., Oshimura M., Kitamura T., Sekiya T., et al. Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers. Oncogene 2001, 20:314-319.
8. Ko J.M., Yau W.L., Chan P.L., Lung H.L., Yang L., Lo P.H., et al. Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32. Genes Chromosomes Cancer 2005, 43:284-293.
9. Kon H., Sonoda Y., Kumabe T., Yoshimoto T., Sekiya T., Murakami Y. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas. Oncogene 1998, 16:257-263.
10. Murakami Y. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene 2002, 21:6936-6948.
11. Phillips K.K., Welch D.R., Miele M.E., Lee J.H., Wei L.L., Weissman B.E. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res 1996, 56:1222-1227.
12. Satoh H., Lamb P.W., Dong J.T., Everitt J., Boreiko C., Oshimura M., et al. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer. Mol Carcinogen 1993, 7:157-164.
13. Chen P., Lin H.H., Weissman B.E. A functional analysis of tumor suppressor activity for peripheral neuroepitheliomas by monochromosome transfer. Oncogene 1995, 10:577-586.
14. Goyette M.C., Cho K., Fasching C.L., Levy D.B., Kinzler K.W., Paraskeva C., et al. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol 1992, 12:1387-1395.
15. Protopopov A.I., Li J., Winberg G., Gizatullin R.Z., Kashuba V.I., Klein G., et al. Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21. J Gene Med 2002, 4:397-406.
16. Cheng Y., Stanbridge E.J., Kong H., Bengtsson U., Lerman M.I., Lung M.L. A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach. Genes Chromosomes Cancer 2000, 28:82-91.
17. Cheng Y., Lung H.L., Wong P.S., Hao D.C., Man C.S., Stanbridge E.J., et al. Chromosome 13q12 region critical for the viability and growth of nasopharyngeal carcinoma hybrids. Int J Cancer 2004, 109:357-362.
18. Cheng Y., Ko J.M., Lung H.L., Lo P.H., Stanbridge E.J., Lung M.L. Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma. Genes Chromosomes Cancer 2003, 37:359-368.
19. Cheung A.K., Lung H.L., Ko J.M., Cheng Y., Stanbridge E.J., Zabarovsky E.R., et al. Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma. Proc Natl Acad Sci USA 2009, 106:14478-14483.
20. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
21. Naylor S.L., Johnson B.E., Minna J.D., Sakaguchi A.Y. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 1987, 329:451-454.
22. Shimizu M., Yokota J., Mori N., Shuin T., Shinoda M., Terada M., et al. Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Oncogene 1990, 5:185-194.
23. Kohno T., Takayama H., Hamaguchi M., Takano H., Yamaguchi N., Tsuda H., et al. Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 1993, 8:1825-1832.
24. Tannergard P., Zabarovsky E., Stanbridge E., Nordenskjold M., Lindblom A. Sublocalization of a locus at 3p21. 3-23 predisposing to hereditary nonpolyposis colon cancer. Hum Genet 1994, 94:210-214.
25. Fullwood P., Marchini S., Rader J.S., Martinez A., Macartney D., Broggini M., et al. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res 1999, 59:4662-4667.
26. Huang D.P., Lo K.W., Choi P.H., Ng A.Y., Tsao S.Y., Yiu G.K., et al. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet Cytogenet 1991, 54:91-99.
27. Lo K., Tsao S., Leung S., Choi P., Lee J., Huang D. Detailed deletion mapping on the short arm of chromosome-3 in nasopharyngeal carcinomas. Int J Oncol 1994, 4:1359-1364.
28. Lerman M.I., Minna J.D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000, 60:6116-6133.
29. Hesson L.B., Cooper W.N., Latif F. Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 2007, 26:7283-7301.
30. Senchenko V.N., Liu J., Loginov W., Bazov I., Angeloni D., Seryogin Y., et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene 2004, 23:5719-5728.
31. Lo P.H., Leung A.C., Kwok C.Y., Cheung W.S., Ko J.M., Yang L.C., et al. Identification of a tumor suppressive critical region mapping to 3p14.2 in esophageal squamous cell carcinoma and studies of a candidate tumor suppressor gene, ADAMTS9. Oncogene 2007, 26:148-157.
32. Lung H.L., Lo P.H., Xie D., Apte S.S., Cheung A.K., Cheng Y., et al. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma. Int J Cancer 2008, 123:401-408.
33. Apte S.S. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. Int J Biochem Cell Biol 2004, 36:981-985.
34. Porter S., Clark I.M., Kevorkian L., Edwards D.R. The ADAMTS metalloproteinases. Biochem J 2005, 386:15-27.
35. Lo P.H., Lung H.L., Cheung A.K., Apte S.S., Chan K.W., Kwong F.M., et al. Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesis. Cancer Res 2010, 70:5567-5576.
36. Cheung A.K., Lung H.L., Hung S.C., Law E.W., Cheng Y., Yau W.L., et al. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. Cancer Res 2008, 68:8137-8145.
37. Sorio C., Mendrola J., Lou Z., LaForgia S., Croce C.M., Huebner K. Characterization of the receptor protein tyrosine phosphatase gene product PTP gamma: binding and activation by triphosphorylated nucleosides. Cancer Res 1995, 55:4855-4864.
38. van Doorn R., Zoutman W.H., Dijkman R., de Menezes R.X., Commandeur S., Mulder A.A., et al. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J Clin Oncol 2005, 23:3886-3896.
39. Wang J.F., Dai D.Q. Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer. World J Gastroenterol 2007, 13:5692-5698.
40. Sun Y., Hegamyer G., Colburn N.H. Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations. Oncogene 1993, 8:791-795.
41. Hwang C.F., Cho C.L., Huang C.C., Wang J.S., Shih Y.L., Su C.Y., et al. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy. Ann Oncol 2002, 13:1246-1251.
42. Li J., Protopopov A., Wang F., Senchenko V., Petushkov V., Vorontsova O., et al. NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes. Proc Natl Acad Sci USA 2002, 99:10724-10729.
43. Law E.W., Cheung A.K., Kashuba V.I., Pavlova T.V., Zabarovsky E.R., Lung H.L., et al. Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene 2011, [Epub ahead of print]. 10.1038/onc.2011.272.
44. de Vega S., Iwamoto T., Yamada Y. Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci 2009, 66:1890-1902.
45. Dunwell T.L., Hesson L.B., Pavlova T., Zabarovska V., Kashuba V., Catchpoole D., et al. Epigenetic analysis of childhood acute lymphoblastic leukemia. Epigenetics 2009, 4:185-193.
46. Hill V.K., Hesson L.B., Dansranjavin T., Dallol A., Bieche I., Vacher S., et al. Identification of 5 novel genes methylated in breast and other epithelial cancers. Mol Cancer 2010, 9:51.
47. Cheng Y., Chakrabarti R., Garcia-Barcelo M., Ha T.J., Srivatsan E.S., Stanbridge E.J., et al. Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13. Genes Chromosomes Cancer 2002, 34:97-103.
48. Lung H.L., Cheng Y., Kumaran M.K., Liu E.T., Murakami Y., Chan C.Y., et al. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma. Int J Cancer 2004, 112:628-635.
49. Kuramochi M., Fukuhara H., Nobukuni T., Kanbe T., Maruyama T., Ghosh H.P., et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 2001, 27:427-430.
50. Murakami Y. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci 2005, 96:543-552.
51. Hui A.B., Lo K.W., Kwong J., Lam E.C., Chan S.Y., Chow L.S., et al. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Mol Carcinogen 2003, 38:170-178.
52. Lung H.L., Cheung A.K., Xie D., Cheng Y., Kwong F.M., Murakami Y., et al. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma. Cancer Res 2006, 66:9385-9392.
53. Lung H.L., Bangarusamy D.K., Xie D., Cheung A.K., Cheng Y., Kumaran M.K., et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 2005, 24:6525-6532.
54. Barker T.H., Grenett H.E., MacEwen M.W., Tilden S.G., Fuller G.M., Settleman J., et al. Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity. Exp Cell Res 2004, 295:488-496.
55. Rege T.A., Thy-1 Hagood J.S. a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta 2006, 1763:991-999.
56. Abeysinghe H.R., Cao Q., Xu J., Pollock S., Veyberman Y., Guckert N.L., et al. THY1 expression is associated with tumor suppression of human ovarian cancer. Cancer Genet Cytogenet 2003, 143:125-132.
57. Lung H.L., Cheung A.K., Cheng Y., Kwong F.M., Lo P.H., Law E.W., et al. Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma. Int J Cancer 2010, 127:304-312.
58. Robertson G.P., Hufford A., Lugo T.G. A panel of transferable fragments of human chromosome 11q. Cytogenet Cell Genet 1997, 79:53-59.
59. Lung H.L., Lo C.C., Wong C.C., Cheung A.K., Cheong K.F., Wong N., et al. Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma. Int J Cancer 2008, 122:1288-1296.
60. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA 1992, 89:10449-10453.
61. Stronach E.A., Sellar G.C., Blenkiron C., Rabiasz G.J., Taylor K.J., Miller E.P., et al. Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression. Cancer Res 2003, 63:8648-8655.
62. Takashi M., Katsuno S., Sakata T., Ohshima S., Kato K. Different concentrations of two small stress proteins, alphaB crystallin and HSP27 in human urological tumor tissues. Urol Res 1998, 26:395-399.
63. Klemenz R., Scheier B., Muller A., Steiger R., Aoyama A. Alpha B crystallin expression in response to hormone, oncogenes and stress. Verh Dtsch Ges Pathol 1994, 78:34-35.
64. Huang Z, Cheng Y, Chiu PM, Cheung FMF, Nicholls JM, Kwong D-W, et al. Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Oncogene. 2011 Dec 12. doi:10.1038/onc.2011.529.
65. Lo K.W., Teo P.M., Hui A.B., To K.F., Tsang Y.S., Chan S.Y., et al. High resolution allelotype of microdissected primary nasopharyngeal carcinoma. Cancer Res 2000, 60:3348-3353.
66. Shao J., Li Y., Wu Q., Liang X., Yu X., Huang L., et al. High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Chin Med J (Engl) 2002, 115:571-575.
67. Kondoh S., Sugawara H., Harada N., Matsumoto N., Ohashi H., Sato M., et al. A novel gene is disrupted at a 14q13 breakpoint of t(2;14) in a patient with mirror-image polydactyly of hands and feet. J Hum Genet 2002, 47:136-139.
68. Baba Y., Tsukuda M., Mochimatsu I., Furukawa S., Kagata H., Satake K., et al. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. Cancer Detect Prev 2001, 25:414-419.
69. Hwang C.F., Su C.Y., Huang S.C., Huang C.C., Fang F.M., Lui C.C., et al. Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma. Cancer Lett 2003, 189:231-236.
70. Cheung A.K., Ko J.M., Lung H.L., Chan K.W., Stanbridge E.J., Zabarovsky E., et al. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-kappaB-mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci USA 2011, 108:8390-8395.
71. Hui A.B., Lo K.W., Leung S.F., Teo P., Fung M.K., To K.F., et al. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation. Int J Cancer 1999, 82:498-503.
72. Karim M.A., Ohta K., Egashira M., Jinno Y., Niikawa N., Matsuda I., et al. Human ESP1/CRP2, a member of the LIM domain protein family: characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3. Genomics 1996, 31:167-176.
73. Sadler I., Crawford A.W., Michelsen J.W., Beckerle M.C. Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J Cell Biol 1992, 119:1573-1587.
74. Wang X., Lee G., Liebhaber S.A., Cooke N.E. Human cysteine-rich protein. A member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J Biol Chem 1992, 267:9176-9184.
75. Tsui S.K., Chan P.P., Cheuk C.W., Liew C.C., Waye M.M., Fung K.P., et al. A novel cDNA encoding for a LIM domain protein located at human chromosome 14q32 as a candidate for leukemic translocation. Biochem Mol Biol Int 1996, 39:747-754.
76. Lo K.W., To K.F., Huang D.P. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 5:423-428.
77. Tao Q., Chan A.T. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007, 9:1-24.
78. Shah K.M., Young L.S. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect 2009, 15:982-988.
79. Sheu J.J., Lee C.H., Ko J.Y., Tsao G.S., Wu C.C., Fang C.Y., et al. Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2009, 18:2709-2716.
80. Nowacki S., Skowron M., Oberthuer A., Fagin A., Voth H., Brors B., et al. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma. Oncogene 2008, 27:3329-3338.
81. Seitz S., Korsching E., Weimer J., Jacobsen A., Arnold N., Meindl A., et al. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression. Genes Chromosomes Cancer 2006, 45:612-627.
82. Yau W.L., Lung H.L., Zabarovsky E.R., Lerman M.I., Sham J.S., Chua D.T., et al. Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma. Int J Cancer 2006, 119:2821-2826.
83. Liu X.Q., Chen H.K., Zhang X.S., Pan Z.G., Li A., Feng Q.S., et al. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Int J Cancer 2003, 106:60-65.
84. Chow L.S., Lo K.W., Kwong J., To K.F., Tsang K.S., Lam C.W., et al. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 2004, 109:839-847.
85. Lo K.W., Kwong J., Hui A.B., Chan S.Y., To K.F., Chan A.S., et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001, 61:3877-3881.
86. Lo K.W., Cheung S.T., Leung S.F., van Hasselt A., Tsang Y.S., Mak K.F., et al. Hypermethylation of the p16 gene in nasopharyngeal carcinoma. Cancer Res 1996, 56:2721-2725.
87. Wang G.L., Lo K.W., Tsang K.S., Chung N.Y., Tsang Y.S., Cheung S.T., et al. Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma. Br J Cancer 1999, 81:1122-1126.
88. Chan K.C., Ko J.M., Lung H.L., Sedlacek R., Zhang Z.F., Luo D.Z., et al. Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. Int J Cancer 2010.
89. Wong V.C., Chen H., Ko J.M., Chan K.W., Chan Y.P., Law S., et al. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer 2012, 30:83-95.
90. Chen H, Ko JMY, Wong VCL, Hyytiainen M, Keski-Oja J, Chiu PM, et al. Latent TGF-β binding protein LTBP-2 is a tumor growth, migration, and angiogenesis suppressor in nasopharyngeal carcinoma, submitted for publication.